A Multi Center Study of Sexual Toxicities After Radiotherapy
ConditionMalignant Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our understanding of why sexual side effects occur and in turn develop predictive models and biomarkers of sexual side effects and other side effects that may impact sexual function. The results of this study may also lead to improvements in the techniques used to deliver radiotherapy or the development of interventions that will prevent or reduce sexual side effects and improve quality of life for female patients with cancer.
Eligibility criteria
Qualifiers
Patients with female sexual organs ages 18 and older.
have been sexually active in the 36 months prior to initiating cancer treatment.
have the intent to be sexually active in the 24 months following treatment..
Patients must be able to provide consent and be willing to participate.
Disqualifiers
planned for or undergone extensive pelvic surgery (e.g. pelvic exenteration, non-TME techniques, or surgeries otherwise affecting pudendal neurovasculature);
have clinically or radiologically detectable widespread metastasis;
have limited life expectancy due to comorbid disease;
have a personal history of cancer other than non-melanoma skin cancer in the last 5 years;
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Icahn School of Medicine at Mount Sinai
Lead sponsor
Emory University
Collaborator
M.D. Anderson Cancer Center
Collaborator
Source ClinicalTrials.gov